Join Olema Oncology as an Executive Assistant to support the CFO and senior leaders in a dynamic biotechnology environment.
Posted by employer 2 months ago
First seen on Joblaze 2 months ago
Last verified on the company career page 1 day ago
Requirements
Not disclosed in this posting: visa sponsorship.
Benefits
Joblaze summary
The Executive Assistant at Olema Oncology plays a crucial role in supporting the Chief Financial Officer and several senior leaders by managing complex calendars, coordinating meetings, and facilitating communication with key stakeholders. This position requires advanced organizational skills and proficiency in tools like Microsoft Office and Concur, along with a background in the biotechnology or pharmaceutical sectors. Ideal candidates will have at least five years of experience in similar roles, demonstrating the ability to thrive in a fast-paced environment while handling sensitive information with discretion.
Joblaze insights
Quick facts
From the original posting
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. With our transformation into a fully integrated oncology company well underway, it’s an exciting time to be part of Team Olema.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in Q1 2027 which, if positive, could lead to our first potential approval and commercial launch in 2028. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant could transform the metastatic breast cancer treatment paradigm and provide access to a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently presented encouraging Phase 1 monotherapy data from this program across multiple solid tumor types, are advancing patient enrollment in the ongoing combination arms in MBC, and expect to initiate a Phase 1 study of OP-3136 in combination with Bayer’s darolutamide in metastatic castration-resistant prostate cancer by the end of this year.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and passionate colleagues dedicated to helping the patients we serve feel better, longer. Team Olema possesses a deep commitment to a shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, the drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. We are a small group of nimble self-starters who bring consistency in our quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the Role >>> Executive Assistant, supporting Chief Financial Officer
We are seeking a highly motivated, resourceful, and experienced Executive Assistant to support our Chief Financial Officer (CFO) and approximately 4–6 senior leaders within the organization. This is a highly visible role that requires exceptional organizational skills, sound judgment, discretion, communication excellence, and the ability to effectively manage multiple priorities in a fast-paced, collaborative environment.
The Executive Assistant will provide seamless administrative support across the CFO leadership team, balancing the needs of multiple executives while helping ensure day-to-day operations run smoothly. You will manage communications and coordinate activities with internal and key external parties, including investors and board members. You will be a trusted partner to the CFO and leadership team, as well as a valued member of the broader Executive Assistant team, collaborating with colleagues to provide outstanding support across the organization.
If you are organized, proactive, collaborative, and energized by supporting executives in a dynamic environment, particularly within the biotechnology or pharmaceutical industry this is a unique opportunity to contribute to our mission to develop innovative medicines for breast cancer and beyond.
This role is based in our San Francisco, CA office and requires an on-site presence four days per week.
Your work will primarily encompass:
Executive Support
Administrative Support & Team Collaboration
Ideal Candidate Profile >>>
A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role.
Knowledge
Experience
Attributes
The base pay range for this position is expected to be $120,000 - $150,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
#LI-AD1
Important Information >>>
Standard company text repeated across Olema Oncology's postings is omitted here.